Narcolepsy with Cataplexy (NT1) research hub

A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Efficacy of TAK-360 for the Treatment of Narcolepsy with Cataplexy (Narcolepsy Type 1)

This clinical trial is testing an experimental medicine called TAK-360 for adults with narcolepsy type 1. Researchers want to see if the medicine is safe and helps reduce daytime sleepiness and sudden muscle weakness (cataplexy). Participants will receive either the study medicine or a dummy pill for comparison.